Response to "Survival from liver transplantation in mitochondrial disorders not only depends on periprocedural complications but on the genotype and mitochondrion-toxic drugs"

Pediatr Transplant. 2021 Dec;25(8):e14122. doi: 10.1111/petr.14122. Epub 2021 Aug 21.

Authors

Hajime Uchida¹, Seisuke Sakamoto¹, Kei Murayama², Mureo Kasahara¹

Affiliations

¹ Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
² Center for Medical Genetics, Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.

PMID: 34418245
DOI: 10.1111/petr.14122

No abstract available

Publication types

Letter
Comment

MeSH terms

Genotype
Humans
Liver Transplantation*
Mitochondria
Mitochondrial Diseases*
Pharmaceutical Preparations*

Substances

Pharmaceutical Preparations